Does Dr. MAI ABDELNABI have financial conflicts of interest?

Dr. MAI ABDELNABI (MD) has received a total of $506 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $506 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MAI ABDELNABI?

According to CMS Open Payments data, Dr. MAI ABDELNABI received funding from GLAXOSMITHKLINE ($147), ASTRAZENECA PHARMACEUTICALS ($134), and AMGEN ($126).

Does Dr. MAI ABDELNABI receive research grants or speaking fees?

Dr. MAI ABDELNABI has received $506 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MAI ABDELNABI

MDReal-Time Hydrated

Specialty: Internal Medicine, Rheumatology

Practice Location: SAN FRANCISCO, CA 94133

NPI Number: 1013394980

LIFETIME INDUSTRY VALUE

$506

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDELNABI is a verified Internal Medicine, Rheumatology practitioner based in SAN FRANCISCO, CA.

Between 2021 and 2024, Dr. ABDELNABI had an overall industry promotional and research financial footprint of $506 as recorded in the federal CMS Open Payments database.

$506 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDELNABI's primary funding source is GLAXOSMITHKLINE, which accounts for $147 (representing 29.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$147

29.1%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$134

26.5%

AMGEN

Rank 3

$126

24.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.